相似文献
1
Colorimetric-plate method for rapid disk diffusion susceptibility testing of Escherichia coli.
J Clin Microbiol. 2011 Mar;49(3):1124-7. doi: 10.1128/JCM.02104-10. Epub 2011 Jan 19.
2
A rapid and sensitive colorimetric measurement of antibiotic efficacy against Escherichia coli in vitro.
FEMS Microbiol Lett. 2016 Apr;363(7). doi: 10.1093/femsle/fnw037. Epub 2016 Feb 17.
3
In-house rapid colorimetric method for detection of colistin resistance in : A significant impact on resistance rates.
J Chemother. 2019 Nov-Dec;31(7-8):432-435. doi: 10.1080/1120009X.2019.1637557. Epub 2019 Jul 17.
4
A new antimicrobial susceptibility testing method of Escherichia coli against ampicillin by MSPQC.
J Microbiol Methods. 2007 Mar;68(3):563-7. doi: 10.1016/j.mimet.2006.10.013. Epub 2006 Dec 18.
5
A simple colorimetric method for testing antimicrobial susceptibility of biofilmed bacteria.
J Microbiol. 2010 Oct;48(5):709-11. doi: 10.1007/s12275-010-0299-z. Epub 2010 Nov 3.
6
Disk diffusion antimicrobial susceptibility testing for clinical and epidemiologic purposes.
Am J Infect Control. 1985 Dec;13(6):241-9. doi: 10.1016/0196-6553(85)90024-0.
7
Susceptibility of ESBL Escherichia coli and Klebsiella pneumoniae to fosfomycin in the Netherlands and comparison of several testing methods including Etest, MIC test strip, Vitek2, Phoenix and disc diffusion.
J Antimicrob Chemother. 2018 Sep 1;73(9):2380-2387. doi: 10.1093/jac/dky214.
8
Comparative evaluation of 2,3-bis [2-methyloxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxanilide (XTT) and 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2, 4-disulfophenyl)-2H-tetrazolium, monosodium salt (WST-8) rapid colorimetric assays for antimicrobial susceptibility testing of staphylococci and ESBL-producing clinical isolates.
J Microbiol Methods. 2007 Dec;71(3):305-11. doi: 10.1016/j.mimet.2007.09.014. Epub 2007 Sep 29.
9
A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes.
Clin Microbiol Infect. 2003 Feb;9(2):120-32. doi: 10.1046/j.1469-0691.2003.00546.x.
10
Comparison of various in vitro susceptibility methods for testing Stenotrophomonas maltophilia.
Diagn Microbiol Infect Dis. 1998 Nov;32(3):229-35. doi: 10.1016/s0732-8893(98)00089-3.
引用本文的文献
1
Proximal Binding Pocket Arg717 Substitutions in Escherichia coli AcrB Cause Clinically Relevant Divergencies in Resistance Profiles.
Antimicrob Agents Chemother. 2022 Apr 19;66(4):e0239221. doi: 10.1128/aac.02392-21. Epub 2022 Mar 21.
2
Is rapid antibacterial susceptibility testing medium reliable for routine laboratory practices?
Pak J Med Sci. 2015 Mar-Apr;31(2):351-4. doi: 10.12669/pjms.312.6683.
3
A real-time PCR antibiogram for drug-resistant sepsis.
PLoS One. 2011;6(12):e28528. doi: 10.1371/journal.pone.0028528. Epub 2011 Dec 2.
本文引用的文献
1
The additional costs of antibiotics and re-consultations for antibiotic-resistant Escherichia coli urinary tract infections managed in general practice.
Int J Antimicrob Agents. 2009 Mar;33(3):255-7. doi: 10.1016/j.ijantimicag.2008.08.027. Epub 2008 Dec 16.
2
Antimicrobial resistance in Europe and its potential impact on empirical therapy.
Clin Microbiol Infect. 2008 Dec;14 Suppl 6:2-8. doi: 10.1111/j.1469-0691.2008.02126.x.
3
Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium.
J Clin Microbiol. 2008 Nov;46(11):3721-7. doi: 10.1128/JCM.00777-08. Epub 2008 Sep 24.
4
Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern.
Lancet Infect Dis. 2008 Mar;8(3):159-66. doi: 10.1016/S1473-3099(08)70041-0.
5
Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use.
J Antimicrob Chemother. 2008 Feb;61(2):428-35. doi: 10.1093/jac/dkm497. Epub 2007 Dec 21.
6
Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam.
Clin Microbiol Infect. 2008 Jan;14 Suppl 1:181-4. doi: 10.1111/j.1469-0691.2007.01864.x.
7
Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe.
Clin Microbiol Infect. 2008 Jan;14 Suppl 1:144-53. doi: 10.1111/j.1469-0691.2007.01850.x.
8
Control of infections due to extended-spectrum beta-lactamase-producing organisms in hospitals and the community.
Clin Microbiol Infect. 2008 Jan;14 Suppl 1:124-33. doi: 10.1111/j.1469-0691.2007.01870.x.
9
Rapid 4 to 6 hour detection of extended-spectrum beta-lactamases in a routine laboratory.
Scand J Infect Dis. 2007;39(9):781-5. doi: 10.1080/00365540701367751.
10
Enterobacteriaceae.
Int J Antimicrob Agents. 2007 May;29 Suppl 3:S9-S22. doi: 10.1016/S0924-8579(07)72174-X.
Zotero 插件